Patents-Review.com
🔗 Permalink
Assignee profile:

Mitobridge, Inc.

City:

Cambridge, Massachusetts

Country:

United States

Published Applications:

21

Last publication date:

2024-01-18

Patent Grants:

20

Last grant date:

2024-02-27

Top Inventors for applications by Mitobridge, Inc.

These are the the leading inventors for applications assigned to Mitobridge, Inc.:

Recent patent applications by Mitobridge, Inc.

Mitobridge, Inc. based in Cambridge, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-01-18 ✅ Patent 11,912,679 granted on 2024-02-27
US20240018113A1
Chemistry; metallurgy

Aryl alkynamide derivatives

 #2 | 2023-08-17 ✅ Patent 11,912,681 granted on 2024-02-27
US20230257360A1
Chemistry; metallurgy

Crystalline and salt forms of PPAR agonist compounds

 #3 | 2022-02-03 ✅ Patent 11,993,585 granted on 2024-05-28
US20220033380A1
Chemistry; metallurgy

Poly-ADP ribose polymerase (PARP) inhibitors

 #4 | 2021-09-16
US20210283116A1
Human necessities

METHODS OF TREATING ACUTE KIDNEY INJURY

 #5 | 2021-08-19 ✅ Patent 11,578,052 granted on 2023-02-14
US20210253549A1
Chemistry; metallurgy

PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof

 #6 | 2021-06-10 ✅ Patent 11,530,192 granted on 2022-12-20
US20210171494A1
Chemistry; metallurgy

Crystalline and salt forms of PPAR agonist compounds

 #7 | 2020-11-05 ✅ Patent 11,358,954 granted on 2022-06-14
US20200347037A1
Chemistry; metallurgy

PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof

 #8 | 2020-09-08 ✅ Patent 10,766,888 granted on 2020-09-08
US16843426
Chemistry; metallurgy

HMOX1 inducers

 #9 | 2020-06-18 ✅ Patent 11,420,934 granted on 2022-08-23
US20200190019A1
Chemistry; metallurgy

PPAR agonists

 #10 | 2020-06-11 ✅ Patent 10,927,094 granted on 2021-02-23
US20200181108A1
Chemistry; metallurgy

Crystalline and salt forms of PPAR agonist compounds

 #11 | 2020-05-21 ✅ Patent 10,906,885 granted on 2021-02-02
US20200157074A1
Chemistry; metallurgy

PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof

 #12 | 2020-04-30 ✅ Patent 11,168,080 granted on 2021-11-09
US20200131172A1
Chemistry; metallurgy

Dynamin-1-like protein inhibitors

 #13 | 2020-04-30 ✅ Patent 10,968,172 granted on 2021-04-06
US20200131121A1
Chemistry; metallurgy

USP30 inhibitors

 #14 | 2020-03-05 ✅ Patent 11,034,670 granted on 2021-06-15
US20200071299A1
Chemistry; metallurgy

Poly-ADP ribose polymerase (PARP) inhibitors

 #15 | 2019-11-07 ✅ Patent 10,479,775 granted on 2019-11-19
US20190337920A1
Chemistry; metallurgy

PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof

 #16 | 2019-09-05 ✅ Patent 10,874,641 granted on 2020-12-29
US20190269655A1
Human necessities

Methods of treating acute kidney injury

 #17 | 2019-03-21 ✅ Patent 10,611,790 granted on 2020-04-07
US20190085008A1
Chemistry; metallurgy

Nicotinamide riboside and nicotinamide mononucleotide derivatives for use in the treatments of mitochondrial-related diseases

 #18 | 2019-03-21 ✅ Patent 10,399,958 granted on 2019-09-03
US20190084958A1
Chemistry; metallurgy

PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof

 #19 | 2018-06-21 ✅ Patent 10,550,071 granted on 2020-02-04
US20180170857A1
Chemistry; metallurgy

PPAR agonists

 #20 | 2017-10-26 ✅ Patent 10,188,627 granted on 2019-01-29
US20170304255A1
Human necessities

PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof

 #21 | 2016-01-28 ✅ Patent 9,938,234 granted on 2018-04-10
US20160023991A1
Chemistry; metallurgy

PPAR agonists

Also check out Mitobridge, Inc.'s (Cambridge, United States) applicant profile with 23 patent applications submitted.

AssigneeID:

104511 ⎘